CYCN - Cyclerion Therapeutics EPS beats by $0.09 misses on revenue November, 09 2021 04:54 PM Cyclerion Therapeutics Inc. Cyclerion Therapeutics (NASDAQ:CYCN): Q3 GAAP EPS of -$0.26 beats by $0.09. Revenue of $0.35M (-12.5% Y/Y) misses by $1.15M. 10-Q Press Release For further details see: Cyclerion Therapeutics EPS beats by $0.09, misses on revenue